je.st
news
Lilly Forecasts Sales, Profit Drop on Rival Generic Drugs
2014-01-08 12:07:12| Biotech - Topix.net
Eli Lilly & Co., the leading U.S. maker of diabetes products, forecast a drop in 2014 profit and reduced its sales outlook because of generic competition to the its Cymbalta antidepressant and Evista drug for osteoporosis.
Tags: sales
drop
profit
drugs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||